Cannformatics

Our mission is to deliver predictable and repeatable science-based medical cannabis outcomes to improve health and quality of life.

[Cannformatics @cannformatics]

Cannformatics: 2025 Highlights https://t.co/v2KMpTGhyE
https://t.co/xhNOMX5al4

[Cannformatics @cannformatics]

We’re announcing a new study on #dementia and medical #cannabis led by @NorthwellHealth at the 2nd Annual New York State Medical Cannabis Symposium.

https://t.co/Upc3betcH7

[Cannformatics @cannformatics]

Proud to see our own @epsteink featured in @CBTmag with an op-ed on how the cannabis industry can better serve people managing complex health conditions—and improve business outcomes. https://t.co/gUrYxohqSx

[Cannformatics @cannformatics]

.@HHSGov's recommendation to move #cannabis to Schedule 3 is a step in the right direction. We're ready to assist @DEAHQ & other agencies with Cannabis-Responsive biomarker data, technology, & expertise needed for establishing therapeutic windows for cannabis-based treatments.

[Cannformatics @cannformatics]

Cannformatics Announces Scientific Reports Publication Revealing Groundbreaking Progress in Personalizing Medical ... https://t.co/8fVYnpXz3R

[Cannformatics @cannformatics]

Thank you @drcaplan for your support.

[Dr Caplan @drcaplan]

Groundbreaking progress in personalizing medical cannabis treatment for Autism Spectrum Disorder (ASD) is on the horizon. Cannformatics is pioneering the use of biomarkers & machine learning to tailor therapies for neuro disorders. How could this change lives! #ASD #CannabisCare

[Cannformatics @cannformatics]

Thrilled to announce the publishing of our 3rd paper in @SciReports revealing our groundbreaking discoveries from combining Cannabis-Responsive #biomarkers and #MachineLearning towards personalizing #medicalcannabis treatment for #ASD #PTSD #Alzheimers https://t.co/dDjFJ7nFdb

[Cannformatics @cannformatics]

@drcaplan @CEDclinic Thank you @drcaplan for your support!

[Cannformatics @cannformatics]

".@Altmetric has tracked 19,731,023 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the TOP 5% of all research outputs EVER TRACKED by Altmetric." https://t.co/1RwrX5a32F

[Cannformatics @cannformatics]

Thank you Caroline Barry and @CannabisHnews for covering this important paper. #biotech #medicalcannabis #cbdhealth #biomarkers #metabolomics #research

[CannabisHealth @CannabisHnews]

Study on autism spectrum disorder (ASD) identifies cannabis-responsive biomarkers in children

@Autism estimates that one in every 100 people are on the autism spectrum with 700,000 adults and children in the UK.

Read more:
https://t.co/JZgeoD8AnG @cannformatics

[Cannformatics @cannformatics]

Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder | Cannabis and Cannabinoid Research https://t.co/2BE32ERnes

[Cannformatics @cannformatics]

Check out our Chief Commercial Officer
@epsteink
discussing Cannabis-Responsive biomarkers on
@TheCBDEDShow1. https://t.co/Wdk6fiAw9g
#medicalcannabis #autism #CBD #biotechnology #research

[Ken Epstein @epsteink]

Great being on the @TheCBDEDShow1 on @VoiceAmVariety talking about @cannformatics #ASD Study. https://t.co/jid2SIn6JA

[Cannformatics @cannformatics]

Thank you @leddder for this great piece in @Medium on our paper in @CannabisJrnl.

[Ken Epstein @epsteink]

Great @Medium post by journalist @leddder on @cannformatics discovery of Cannabis Responsive #biomarkers to measure #medicalcannabis’ impact on children with #autism. https://t.co/0Ax7GspLI0

[Cannformatics @cannformatics]

Cannformatics Discovers Tool For Objectively Measuring Medical Cannabis Benefits In Children With Autism | Benzinga https://t.co/DbZsM1Pt5G via @benzinga

[Cannformatics @cannformatics]

Excited to see over 3-years of #biotechnology research and the participation of the children and their families be validated by the publishing of this paper. This is the first step in advancing precision #medicalcannabis & #CBD treatment. #autism

[Cannabis and Cannabinoid Research Journal @CannabisJrnl]

Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with #AutismSpectrumDisorder

Read Now: https://t.co/SzTuLDg4Ys

[Cannformatics @cannformatics]

First study to use Cannabis-Responsive #biomarkers to examine the #metabolic response in saliva of children with #ASD treated with various #medicalcannabis or #CBD products widely available in licensed California dispensaries. https://t.co/yiPqnlvApv

[Cannformatics @cannformatics]

Cannformatics Scientific Advisor Dr. Donald Abrams comments on the the challenges clinicians and #breastcancer patients face when discussing the use of #MedicalCannabis in relieving treatment side effects. https://t.co/91ASaB5H7e

[Cannformatics @cannformatics]

We're excited to welcome medical #cannabis expert Dr. Bonni Goldstein to our esteemed Advisory Board. Dr. Goldstein will provide advise on our #clinical studies used to identify Cannabis-Responsive #biomarkers https://t.co/vuy7mmif8K

[Cannformatics @cannformatics]

We're excited to welcome Congressman Edward Feighan to our Advisory Board. Mr. Feighan's #canabinoid-based, #pharma and #policy making experience makes him a welcome addition to the Cannformatics team. https://t.co/hglgmELiom

[Cannformatics @cannformatics]

Proud to welcome @canniatric and @wpa4a as sponsors of our #autism spectrum disorder pilot study. This is the first #IRB approved study to assess the impact of #medicalcannabis using #biomarkers found in saliva. #metabolomics #asd https://t.co/TOSlRVjeLv